235 related articles for article (PubMed ID: 34733735)
1. Case report: identification of
Ma J; Wang B; Meng E; Meng X
Gland Surg; 2021 Sep; 10(9):2874-2879. PubMed ID: 34733735
[TBL] [Abstract][Full Text] [Related]
2. RET fusions in solid tumors.
Li AY; McCusker MG; Russo A; Scilla KA; Gittens A; Arensmeyer K; Mehra R; Adamo V; Rolfo C
Cancer Treat Rev; 2019 Dec; 81():101911. PubMed ID: 31715421
[TBL] [Abstract][Full Text] [Related]
3. Targeted Therapy for RET Fusion Lung Cancer: Breakthrough and Unresolved Issue.
Takamori S; Matsubara T; Haratake N; Toyokawa G; Fujishita T; Toyozawa R; Ito K; Yamaguchi M; Taguchi K; Okamoto T; Seto T
Front Oncol; 2021; 11():704084. PubMed ID: 34497761
[TBL] [Abstract][Full Text] [Related]
4. Pralsetinib for the treatment of a
Meng Y; Li L; Wang H; Chen X; Yue Y; Wang M; Meng L; Li B; Li X
Ann Transl Med; 2022 Apr; 10(8):496. PubMed ID: 35571397
[TBL] [Abstract][Full Text] [Related]
5. Decade in review: a new era for RET-rearranged lung cancers.
Choudhury NJ; Drilon A
Transl Lung Cancer Res; 2020 Dec; 9(6):2571-2580. PubMed ID: 33489819
[TBL] [Abstract][Full Text] [Related]
6. Predictive molecular pathology in metastatic thyroid cancer: the role of
Nacchio M; Pisapia P; Pepe F; Russo G; Vigliar E; Porcelli T; Luongo C; Iaccarino A; Pagni F; Salvatore D; Troncone G; Malapelle U; Bellevicine C
Expert Rev Endocrinol Metab; 2022 Mar; 17(2):167-178. PubMed ID: 35404189
[TBL] [Abstract][Full Text] [Related]
7. RET Inhibitors in Non-Small-Cell Lung Cancer.
Cascetta P; Sforza V; Manzo A; Carillio G; Palumbo G; Esposito G; Montanino A; Costanzo R; Sandomenico C; De Cecio R; Piccirillo MC; La Manna C; Totaro G; Muto P; Picone C; Bianco R; Normanno N; Morabito A
Cancers (Basel); 2021 Sep; 13(17):. PubMed ID: 34503226
[TBL] [
